COMMUNIQUÉS West-GlobeNewswire
-
Jabra Enhance introduces a new lineup of FDA-cleared self-fitting hearing aids, 3 new models with improved hearing technology and in-app self-tuning
18/08/2026 -
NeOnc Technologies- Talk Is Cheap, Insider Buying Isn’t
18/08/2026 -
Trethera Appoints World-Renowned ALS Researcher Dr. Merit Cudkowicz to Scientific Advisory Board
18/08/2026 -
USAHS Celebrates 20,000 Degrees Amid Continued Growth and Program Expansion
18/08/2026 -
Ketogenic Foundation Announces 2026 Conference Exploring the Future of Metabolic Health and Chronic Disease Care
18/08/2026 -
U.S. Oral Surgery Management Partners with Cottonwood Oral & Maxillofacial Surgery of Albuquerque
18/08/2026 -
SK pharmteco Marks Construction Progress with Ribbon Cutting for Two Advanced Manufacturing Facilities at Swords, Ireland Campus
18/08/2026 -
Applied Biologics Announces Acceptance of XWRAP® Translational Research for Presentation at SAWC Fall 2026
18/08/2026 -
Coloplast A/S - Interim Financial Report, 9M 2025/26
18/08/2026 -
DLH to Provide Mission-Critical Cyber Support for U.S. Navy
18/08/2026 -
BayCare Names Lawrence "Wren" Roberts to New Vice President of Support Services Role
18/08/2026 -
Craif Raises $33M to Accelerate Introduction of Its Urine-Based Cancer Test to the U.S.
18/08/2026 -
Society for Science selects 100 educators for the 2026–2027 Advocate Program, investing $326,000 to expand student access to scientific research and science competitions
18/08/2026 -
DARÉ Bioscience CEO Sabrina Martucci Johnson Named to Forbes 2026 “50 Over 50: Innovation” List
18/08/2026 -
Syneos Health Advances AI-Powered Clinical Ecosystem to Optimize Trial Performance and Speed Decision-Making
18/08/2026 -
Conexeu Sciences Sees a New Category Forming in Medical Aesthetics as Research Turns to Regeneration
18/08/2026 -
Polomar Health Services Reports Second-Quarter Revenue of $1.53 Million and Positive Net Income
18/08/2026 -
ENvue Medical Announces Exclusive UroShield® Distribution Agreement with Minimum Purchase Commitments of Approximately $2.6 Million
18/08/2026 -
Propanc Biopharma Clears Path for World-First Phase 1b Clinical Study of Breakthrough Cancer Therapy PRP
18/08/2026
Pages